Delivery Order SPE2DR25D2012-SPE2DR26F1BJZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,338.65 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This order, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a firm fixed-price procurement with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.11 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 18, 2025. This competitive, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,149.57 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.30 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with performance completed in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, and carries no set-aside designation. This...
- The Defense Logistics Agency has awarded a delivery order valued at $3,232.63 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,581.32 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,331.08 for Ambien CR 6.25 mg tablets (100-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The pharmaceutical distributor will perform the delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,820.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on November 12, 2025, with a completion date of November 13, 2025. This competitively awarded, non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BJZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,044.23 to AmerisourceBergen Drug Corp for supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price delivery order with no set-aside designation, competitively awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems, with a demonstrated portfolio of successful contract awards across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/17/25 |